{"id":61398,"date":"2025-08-31T13:11:23","date_gmt":"2025-08-31T07:41:23","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=61398"},"modified":"2025-09-02T13:47:18","modified_gmt":"2025-09-02T08:17:18","slug":"bioe3-policy-indias-push-for-biomanufacturing-hubs","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/bioe3-policy-indias-push-for-biomanufacturing-hubs\/","title":{"rendered":"BioE3 Policy &#8211; India\u2019s Push for Biomanufacturing Hubs"},"content":{"rendered":"<h2 style=\"text-align: justify;\"><strong>BioE3 Policy Latest News<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India remains heavily <\/span><b>dependent on imports<\/b><span style=\"font-weight: 400;\"> for active pharmaceutical ingredients (<\/span><b>APIs<\/b><span style=\"font-weight: 400;\">), fermentation-based drugs, enzymes for biofuels, and biofertilizer reagents.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Post Covid-19 pandemic, the government has <\/span><b>accelerated efforts for domestic manufacturing<\/b><span style=\"font-weight: 400;\"> under policies like the PLI scheme.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The Biotechnology for Economy, Environment, and Employment (BioE3) policy\/ <\/span><b>BioE3 policy<\/b><span style=\"font-weight: 400;\"> of the Government of India envisions setting up 16 biomanufacturing hubs to strengthen the bioeconomy and ensure self-reliance (Atmanirbharta).<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>India\u2019s Bioeconomy<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>The bioeconomy<\/b><span style=\"font-weight: 400;\"> is an economic system that utilizes renewable biological resources from plants, animals, and microorganisms\u2014along with organic waste\u2014to create food, feed, energy, and bio-based products.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">As in December 2023, Bioeconomy contributes <\/span><b>4.25%<\/b><span style=\"font-weight: 400;\"> to India\u2019s Gross Domestic Product (GDP).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Indian Bioeconomy has grown from <\/span><b>$10 billion in 2014 to $151 billion in 2023<\/b><span style=\"font-weight: 400;\">, achieving this target two years ahead of projections for 2025.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>The number of Biotech Startups<\/b><span style=\"font-weight: 400;\"> has grown from 50 Biotech Startups in 2014 to 8,531 Biotech Startups in 2023.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>About the BioE3 Policy<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Launched on August 27, 2024, it is a Union S&amp;T Ministry\u2019s policy that sets forth a framework to <\/span><b>ensure the adoption of cutting-edge advanced technologies<\/b><span style=\"font-weight: 400;\"> for <\/span><b>promoting Biomanufacturing<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The policy outlines guidelines and principles for enabling mechanisms for \u2018<\/span><b>Fostering High Performance Biomanufacturing<\/b><span style=\"font-weight: 400;\">\u2019 in the country across diverse sectors.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is aligned with India\u2019s vision of <\/span><b>Green Growth<\/b><span style=\"font-weight: 400;\"> and also with the Lifestyle for Environment (<\/span><b>LiFE<\/b><span style=\"font-weight: 400;\">) initiative that envisions collective approach towards sustainability.\u00a0<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Key Features of the BioE3 Policy<\/strong><\/h2>\n<ul>\n<li aria-level=\"1\"><b>Biomanufacturing hubs:<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">Around <\/span><b>16 hubs<\/b><span style=\"font-weight: 400;\"> to be set up across India.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Each hub will house large fermenters (500\u20131,000 litres).<\/span><\/li>\n<li><b>Focus<\/b><span style=\"font-weight: 400;\">: Fermentation-based medicines, biofuels, bioproteins, carbon capture technologies, and novel monoclonal antibody treatments.<\/span><\/li>\n<li><b>Hubs will pool resources<\/b><span style=\"font-weight: 400;\"> \u2192 reducing capital burden for start-ups and MSMEs.<\/span><\/li>\n<\/ul>\n<\/li>\n<li aria-level=\"1\"><b>Product focus:<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">The government has listed <\/span><b>approximately 1,000 critical products<\/b><span style=\"font-weight: 400;\"> needed for indigenous manufacturing.<\/span><\/li>\n<li aria-level=\"2\"><b>Categories:<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">APIs and drugs<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Enzymes for biofuels<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Reagents for biofertilizers<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Smart proteins and nutrition enhancers<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Carbon capture innovations<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Biofoundries &#8211; The First Step<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>6 Biofoundries<\/b><span style=\"font-weight: 400;\"> already supported by Department of Biotechnology (DBT):<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">NABI, Mohali, for sustainable food &amp; nutrition.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Tata Memorial Centre, for new drugs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">ICGEB, New Delhi, for synthetic biology, microbial cells, biofuels, carbon capture.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">THSTI, Faridabad, for monoclonal antibody therapies.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">IPFT, Gurugram, for biopesticides.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">NCCS, Pune, for enzymes and metabolites.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Function<\/b><span style=\"font-weight: 400;\">: Conduct proof-of-concept testing, and innovations are transferred to hubs for scaling up.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Implementation Model<\/strong><\/h2>\n<ul>\n<li><b>Location<\/b><span style=\"font-weight: 400;\">: The biomanufacturing hubs will be set up within research institutes, private companies, or near knowledge hubs.<\/span><\/li>\n<li><b>Accessibility: <\/b><span style=\"font-weight: 400;\">Open to government R&amp;D labs, universities, start-ups, and private industry.<\/span><\/li>\n<li><b>Cost-sharing model: <\/b><span style=\"font-weight: 400;\">The <\/span><b>start-ups<\/b><span style=\"font-weight: 400;\"> will be charged a maximum of 5% over the actual costs while <\/span><b>private companies <\/b><span style=\"font-weight: 400;\">may be charged up to 15% over the cost.<\/span><\/li>\n<li><b>IPR policy<\/b><span style=\"font-weight: 400;\">: Facilities will not claim IP rights, ensuring innovation ownership with developers.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Significance of BioE3 Policy for India<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Reduces import <\/b><span style=\"font-weight: 400;\">dependency in critical pharma and bio-based sectors.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Strengthens bioeconomy and aligns with <\/span><b>Atmanirbhar Bharat <\/b><span style=\"font-weight: 400;\">vision.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Supports innovation<\/b><span style=\"font-weight: 400;\">-to-market pipeline through biofoundries \u2192 hubs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Boosts R&amp;D <\/b><span style=\"font-weight: 400;\">collaboration among government, academia, and industry.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Promotes start-up<\/b><span style=\"font-weight: 400;\"> ecosystem in biotechnology.<\/span><\/li>\n<\/ul>\n<h2 style=\"text-align: justify;\"><strong>Conclusion<\/strong><\/h2>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The BioE3 policy, by integrating biofoundries with biomanufacturing hubs, positions India to emerge as <\/span><b>a global leader in biotechnology-driven solutions<\/b><span style=\"font-weight: 400;\"> for health, energy, and agriculture.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Going forward, sustained investment, industry-academia collaboration, and supportive regulatory frameworks will be key to realising the vision of <\/span><b>a self-reliant and innovation-led bioeconomy.<\/b><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><b>Source: <\/b><a href=\"https:\/\/indianexpress.com\/article\/india\/govt-plans-to-cut-down-on-imports-of-pharma-agents-biofuel-enzymes-10221213\/\" target=\"_blank\" rel=\"nofollow noopener\"><b>IE<\/b><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The BioE3 policy envisions setting up 16 biomanufacturing hubs to strengthen the bioeconomy and ensure self-reliance (Atmanirbharta).<\/p>\n","protected":false},"author":19,"featured_media":61581,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[2421,60,22,59],"class_list":{"0":"post-61398","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-upsc-mains-current-affairs","8":"tag-bioe3-policy","9":"tag-mains-articles","10":"tag-upsc-current-affairs","11":"tag-upsc-mains-current-affairs","12":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/61398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=61398"}],"version-history":[{"count":0,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/61398\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/61581"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=61398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=61398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=61398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}